News

Biomarker Technologies and TIANGEN Biotech signed a strategic cooperation agreement in the European market

On February 5, 2024, Biomarker Technologies (BMKGENE) and TIANGEN Biotech (Beijing)Co., Ltd. signed a strategic cooperation agreement in the European market. BMKGENE becomes the strategic partner for TIANGEN TGuide S16 automated nucleic acid extractor and reagents in 10 European countries, further expanding the service matrix in the field of life sciences and providing customers with more comprehensive and diversified one-stop sequencing solutions. At the same time, BMKGENE will create deeper cooperation with TIANGEN in the field of laboratory automatization, taking market demand as the starting point to provide our customers with customized sequencing solutions from nucleic acid extraction to bioinformatics analysis. The cooperation combines the resource advantages of both parties to promote the expansion of the biotechnology market, achieving the strategic goal of win-win cooperation and empower the biotechnology industry.

(Chunyu Xiu, General Manager of BMKGENE Overseas Business Department and Xiaowen Wu, Sales Director of TIANGEN's Export Department)

TIANGEN is a biological high-tech enterprise integrating R&D, manufacturing, sales and customer service. It has been committed to providing customers with comprehensive solutions from sample preparation to nucleic acid extraction and detection. The TGuide S16 automated nucleic extractor, self-developed by TIANGEN adopts an intelligent operating system. It is lightweight and convenient, and can provide comprehensive, complete and high-quality automation solutions for various samples. BMKGENE and TIANGEN work together to promote the sales and services of automated nucleic acid extractor in Europe. BMKGENE will give full play to its customer resource advantages in high-throughput sequencing, actively promote cooperation between the two parties, and further increase market share and brand influence. Meanwhile, BMKGENE and TIANGEN establish a close cooperative relationship in terms of technical support and after-sales service to provide customers with excellent service experience.

Chunyu Xiu, General Manager of BMKGENE Overseas Business Department, said:

TIANGEN is a leading provider in the field of nucleic acid purification and has been a long-term partner of BMKGENE. We're happy to cooperate with TIANGEN and be the strategic partner in the European market. Based on BMKGENE's accumulation and experience in high-throughput sequencing and TIANGEN empowerment in automatic nucleic acid extraction solutions, BMKGENE continuously provides more diversified and higher-quality one-stop sequencing solutions from nucleic acid sample extraction to bioinformatics analysis for the European and even global customers.

Xiaowen Wu, Sales Director of TIANGEN's Export Department, said:

We are very pleased to have reached this in-depth cooperation with BMKGENE. BMKGENE is one of the leading genomics service providers, having established overseas molecular laboratories and it will continue to expand its overseas business. We believe that our products can compete with BMKGENE's achieve synergy with sequencing services and we can work together to develop the international market. This in-depth cooperation will bring more opportunities and development space for both of us.

About BMKGENE

Biomarker Technologies(BMKGENE), as one of the leading providers of genomics services, was founded in 2009, headquartered in Beijing, China. BMKGENE has been actively engaged in innovation and development of high-throughput sequencing technologies and bioinformatics for over 14 years. Its business consists of science and technology services and BioCloud bioinformatics platform. BMKGENE has established long-term cooperation with various organizations, including universities, hospitals, research institutes, independent laboratories, pharmaceutical companies, plant breeding companies, medical and health institutes, etc., sitting in over 50 regions all over the world.

BMKGENE owns a passionate and highly-skilled R&D team of over 500 members composed of highly-educated technical staff, senior engineers, bioinformaticians and experts in diverse areas including biotechnology, agriculture, medicine, computing, etc. Our outstanding technical team has robust ability in tackling scientific and technical issues and has accumulated massive experience in diverse research area and contributed in hundreds of high-impact publications in Nature, Nature Genetics, Nature Communications, Plant Cell, etc. It owns over 60 national patents of inventions and 200 software copyrights.

About TIANGEN

TIANGEN BIOTECH (BEIJING) CO.,LTD. is a high-tech biological enterprise integrating R&D, production, sales, and customer service. It has been committed to providing customers with a complete solution from sample storage to nucleic acid extraction and detection. Currently it is a recognized leader in nucleic acid purification and extraction in the Chinese market.

TIANGEN's product line includes genomic DNA extraction, RNA extraction, plasmid extraction, DNA clean-up and gel recovery, PCR/RT-PCR and qPCR products, epigenetics related (miRNA extraction and detection kits and methylation related kits), next-generation sequencing (NGS) library construction products and technology services, cloning and point mutation products, cell-free protein expression, protein detection related products. It also provides integrated solutions for laboratory commonly used in instruments and automated workstations, automated nucleic acid extractor and supporting reagents, as well as the reagents for open mainstream automated nucleic acid extraction platforms.